Genetic Signatures Ltd - Asset Resilience Ratio

Latest as of June 2025: 57.28%

Genetic Signatures Ltd (GSS) has an Asset Resilience Ratio of 57.28% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Genetic Signatures Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$31.30 Million

≈ $22.14 Million USD Cash + Short-term Investments

Total Assets

AU$54.63 Million

≈ $38.65 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Genetic Signatures Ltd's Asset Resilience Ratio has changed over time. See Genetic Signatures Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Genetic Signatures Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Genetic Signatures Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$7.47 Million	13.68%
Short-term Investments	AU$23.82 Million	43.61%
Total Liquid Assets	AU$31.30 Million	57.28%

Asset Resilience Insights

Very High Liquidity: Genetic Signatures Ltd maintains exceptional liquid asset reserves at 57.28% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Genetic Signatures Ltd Industry Peers by Asset Resilience Ratio

Compare Genetic Signatures Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	6.56%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Genetic Signatures Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Genetic Signatures Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	43.61%	AU$23.82 Million ≈ $16.86 Million	AU$54.63 Million ≈ $38.65 Million	-4.55pp
2024-06-30	48.15%	AU$32.40 Million ≈ $22.93 Million	AU$67.29 Million ≈ $47.61 Million	+27.78pp
2023-06-30	20.38%	AU$10.00 Million ≈ $7.08 Million	AU$49.08 Million ≈ $34.73 Million	-21.53pp
2022-06-30	41.91%	AU$25.00 Million ≈ $17.69 Million	AU$59.65 Million ≈ $42.21 Million	-4.35pp
2021-06-30	46.26%	AU$25.00 Million ≈ $17.69 Million	AU$54.05 Million ≈ $38.24 Million	+16.08pp
2020-06-30	30.17%	AU$15.00 Million ≈ $10.61 Million	AU$49.72 Million ≈ $35.18 Million	-21.86pp
2019-06-30	52.03%	AU$6.31 Million ≈ $4.47 Million	AU$12.13 Million ≈ $8.58 Million	-9.27pp
2018-06-30	61.30%	AU$8.95 Million ≈ $6.34 Million	AU$14.61 Million ≈ $10.34 Million	-13.34pp
2017-06-30	74.64%	AU$13.19 Million ≈ $9.33 Million	AU$17.67 Million ≈ $12.51 Million	--

pp = percentage points

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$14.14 Million

AU$19.99 Million AUD

Market Cap Rank

#26008 Global

#1223 in Australia

Share Price

AU$0.09

Change (1 day)

+7.32%

52-Week Range

AU$0.08 - AU$0.68

All Time High

AU$2.75